The immune response to HIV gp120 induced by nucleic acid immunization (NAI).
Peet
N
N
Department of Immunology, University College London Medical School, United Kingdom.
Delves
P J
PJ
de Souza
B
B
Cambridge
G
G
Wilkinson
L
L
Klonisch
T
T
Matear
P
P
Vyakarnam
A
A
Lund
T
T
D016915:AIDS Vaccines / Q000008:administration & dosage; D000818:Animals; D003587:Cytomegalovirus / Q000235:genetics; D004274:DNA, Recombinant / Q000008:administration & dosage; D005822:Genetic Vectors / Q000235:genetics; D015483:HIV Antibodies / Q000096:biosynthesis* / Q000276:immunology; D015699:HIV Envelope Protein gp120 / Q000235:genetics / Q000276:immunology*; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007273:Injections, Intramuscular; D051379:Mice; D008808:Mice, Inbred CBA; D017924:Nucleopolyhedroviruses / Q000235:genetics; D011401:Promoter Regions, Genetic; D011993:Recombinant Fusion Proteins / Q000276:immunology*; D010959:Tissue Plasminogen Activator / Q000235:genetics
D016915:AIDS Vaccines; D004274:DNA, Recombinant; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; D011993:Recombinant Fusion Proteins; D010959:Tissue Plasminogen Activator